This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Seattle Children's Hospital, University of Cape Town. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 89 
1 out of 94 
Years Active: 2022
Title: Willem Albert Hanekom: Innovator in Tuberculosis Prognostics
Introduction
Willem Albert Hanekom is a notable inventor based in Cape Town, South Africa. He has made significant contributions to the field of medical diagnostics, particularly in the area of tuberculosis (TB) research. His innovative work focuses on the early detection and risk assessment of active tuberculosis disease.
Latest Patents
Willem Albert Hanekom holds a patent for "Biomarkers for prospective determination of risk for development of active tuberculosis." This invention relates to a prognostic method that determines the risk of an asymptomatic human subject with latent TB infection progressing to active tuberculosis disease. The method involves quantifying and computationally analyzing the relative abundances of pairs of gene products, known as TB biomarkers, derived from samples obtained from the subject. The invention also includes a collection of TB biomarkers that generates a transcriptomic signature of risk, which aids in predicting the likelihood of progression to active disease. Additionally, it describes a kit comprising gene-specific primers or oligonucleotide probes for detecting these biomarkers, facilitating the prognostic method. Furthermore, the invention outlines a method for preventive treatment or prophylaxis for TB infection, utilizing the prognostic method and kit to select appropriate treatment regimes.
Career Highlights
Throughout his career, Hanekom has worked with esteemed institutions such as Seattle Children's Hospital and the University of Cape Town. His work has significantly advanced the understanding of tuberculosis and its management.
Collaborations
Some of his notable coworkers include Adam Garth Penn-Nicholson and Thomas Jens Scriba, who have collaborated with him on various research projects related to tuberculosis.
Conclusion
Willem Albert Hanekom's innovative contributions to tuberculosis research highlight the importance of early detection and risk assessment in managing this infectious disease. His work continues to impact the field of medical diagnostics and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile